Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
Completed · Phase 3
Conditions studied: Advanced Malignancies
In brief
This is an open-label, multicenter, extension study to evaluate the long-term safety and efficacy of BeiGene or BeOne investigational drugs in participants with advanced malignancies who participated in a prior BeiGene- or BeOne-sponsored clinical study (parent study).
Key facts
- Study ID
- NCT04164199
- Run by
- BeOne Medicines
- People needed
- 404
- Starts
- 2019-12-19
- Expected to finish
- 2026-05-23
- Last updated by the study team
- 2026-06-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Memorial Sloan Kettering Cancer Center Mskcc — New York, New York, United States
- Tennessee Oncology, Pllc Nashville — Nashville, Tennessee, United States
- Baylor Research Institute — Dallas, Texas, United States
- Prince of Wales Hospital — Randwick, New South Wales, Australia
- Northern Cancer Institute — St Leonards, New South Wales, Australia
- Calvary Mater Newcastle — Waratah, New South Wales, Australia
- Icon Cancer Centre South Brisbane — South Brisbane, Queensland, Australia
- The Queen Elizabeth Hospital — Woodville South, South Australia, Australia
- Monash Health — Clayton, Victoria, Australia
- Peter Maccallum Cancer Centre — Melbourne, Victoria, Australia
- The Second Hospital of Anhui Medical University — Hefei, Anhui, China
- Cancer Hospital Chinese Academy of Medical Sciences — Beijing, Beijing Municipality, China
- Peking University First Hospital — Beijing, Beijing Municipality, China
- The Affiliated Hospital of Military Medical Sciences — Beijing, Beijing Municipality, China
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Chongqing Cancer Hospital — Chongqing, Chongqing Municipality, China
- Fujian Medical University Union Hospital — Fuzhou, Fujian, China
- Fujian Cancer Hospital — Fuzhou, Fujian, China
- The First Affiliated Hospital of Xiamen University — Xiamen, Fujian, China
- Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North) — Guangzhou, Guangdong, China
- Affiliated Cancer Hospital and Institute of Guangzhou Medical University — Guangzhou, Guangdong, China
- Guangdong Provincial Peoples Hospital — Guangzhou, Guangdong, China
- Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South) — Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University — Guangzhou, Guangdong, China
- Mount Sinai Medical Center Braman Comprehensive Cancer Center — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.